Magazine: Challenges in multiple drugs safety reporting
In this issue: Challenges in pharmacovigilance for treatments involving multiple drugs, the potential of 3D printing in drug manufacturing, opportunities in value-based pricing, and more.
By
Susanne Hauner is the publisher of Verdict's digital magazines.
In this issue: Challenges in pharmacovigilance for treatments involving multiple drugs, the potential of 3D printing in drug manufacturing, opportunities in value-based pricing, and more.
By Susanne HaunerIn this issue: Maximising investment by cancer megafunds, positive clinical trials for an antibody to treat lupus, how copper…
By Susanne HaunerIn this issue: The breast cancer drug pipeline, getting biosimilars to market, the debate about animal research, olive leaf…
By Susanne HaunerIn this issue: Bridging the GP - big pharma divide, the year ahead in regulation, world-changing research into parasitic…
By Susanne HaunerIn this issue: regulation updates for EU-FMD and IDMP, why flibanserin remains controversial, why farm dust could be the…
By Susanne HaunerIn this issue: How the industry can prepare for Britain’s EU referendum, London’s proposed £10bn drug development ‘megafund’, why…
By Susanne HaunerIn this issue: South Africa's long road to domestic manufacturing, the 21st Century Cures Act divides opinion in the…
By Susanne HaunerIn this issue: New findings on fake medicines, progress in predicting cancer, the rocky road ahead for biosimilars developers,…
By Susanne HaunerIn this issue: A new gene therapy for lung cancer, a new approach to hepatitis B vaccines, tackling obesity…
By Susanne HaunerThank you for subscribing to Pharmaceutical Technology